ALLO
Allogene Therapeutics, Inc. · Healthcare
President and CEO David D Chang sold $181K of Allogene Therapeutics, Inc.
Sold$180,879
$7.65Price
23,648Shares
What ALLO did after the filing
- The stock from Thu, Mar 17 close, $9.00
- −7.2%
- S&P 500, same days
- −6.3%
Measured over 30 trading days, to the Apr 29 close.
Traded Tue, Mar 15. Filed Thu, Mar 17, 1:59 PM ET, during the session. Returns use the Mar 17 close and the Apr 29 close. Not investment advice.